Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-17 to 2024-07-02
Current total value of award: $286.98
Description: 8510702301!HEPATITIS B VIRUS V